FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

387023000: Bexarotene (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2003. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1461201018 Bexarotene (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
1481137011 Bexarotene en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bexarotene Is a Antineoplastic agent true Inferred relationship Existential restriction modifier
Bexarotene Is a Naphthalene true Inferred relationship Existential restriction modifier
Bexarotene Is a Retinoid true Inferred relationship Existential restriction modifier
Bexarotene Is a Benzoic acid true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing bexarotene Has active ingredient True Bexarotene Inferred relationship Existential restriction modifier 1
Product containing precisely bexarotene 75 milligram/1 each conventional release oral capsule Has active ingredient False Bexarotene Inferred relationship Existential restriction modifier
Product containing bexarotene in oral dose form (medicinal product form) Has active ingredient True Bexarotene Inferred relationship Existential restriction modifier 1
Product containing bexarotene in topical dosage form Has active ingredient False Bexarotene Inferred relationship Existential restriction modifier
Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug) Has active ingredient False Bexarotene Inferred relationship Existential restriction modifier
Product containing precisely bexarotene 75 milligram/1 each conventional release oral capsule Has active ingredient False Bexarotene Inferred relationship Existential restriction modifier 1
Product containing precisely bexarotene 75 milligram/1 each conventional release oral capsule Has basis of strength substance True Bexarotene Inferred relationship Existential restriction modifier 1
Product containing precisely bexarotene 75 milligram/1 each conventional release oral capsule Has precise active ingredient True Bexarotene Inferred relationship Existential restriction modifier 1
Product containing bexarotene in cutaneous dose form (medicinal product form) Has active ingredient True Bexarotene Inferred relationship Existential restriction modifier 1
Bexarotene Has active ingredient True Bexarotene Inferred relationship Existential restriction modifier 1
Product containing only bexarotene in cutaneous dose form (medicinal product form) Has active ingredient True Bexarotene Inferred relationship Existential restriction modifier 1
Product containing only bexarotene in oral dose form (medicinal product form) Has active ingredient True Bexarotene Inferred relationship Existential restriction modifier 1
Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug) Has precise active ingredient True Bexarotene Inferred relationship Existential restriction modifier 1
Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug) Has basis of strength substance True Bexarotene Inferred relationship Existential restriction modifier 1
Bexarotene 75mg capsules (Celix Pharma Ltd) Has specific active ingredient True Bexarotene Inferred relationship Existential restriction modifier
Bexarotene 75mg capsules (Celix Pharma Ltd) 100 capsule Has specific active ingredient True Bexarotene Inferred relationship Existential restriction modifier
Targretin 75mg capsule Has active ingredient False Bexarotene Inferred relationship Existential restriction modifier
Bexarotene 75mg capsule - product Has active ingredient False Bexarotene Inferred relationship Existential restriction modifier
Product containing precisely bexarotene 75 milligram/1 each conventional release oral capsule Has active ingredient False Bexarotene Inferred relationship Existential restriction modifier
Targretin 75mg capsules (Medeus Pharma) Has active ingredient False Bexarotene Inferred relationship Existential restriction modifier
Bexarotene 75mg capsules 100 capsule Has active ingredient False Bexarotene Inferred relationship Existential restriction modifier
Targretin 75mg capsules (Medeus Pharma) 100 capsule Has active ingredient False Bexarotene Inferred relationship Existential restriction modifier
Bexarotene 75mg capsules (Cipla EU Ltd) 100 capsule Has specific active ingredient True Bexarotene Inferred relationship Existential restriction modifier
Bexarotene 75mg capsules (Cipla EU Ltd) Has specific active ingredient True Bexarotene Inferred relationship Existential restriction modifier
Targretin 75mg capsules (Medeus Pharma) 100 capsule Has specific active ingredient True Bexarotene Inferred relationship Existential restriction modifier
Targretin 75mg capsules (Medeus Pharma) Has specific active ingredient True Bexarotene Inferred relationship Existential restriction modifier
Product containing precisely bexarotene 75 milligram/1 each conventional release oral capsule Has specific active ingredient True Bexarotene Inferred relationship Existential restriction modifier
Bexarotene 75mg capsules 100 capsule Has specific active ingredient True Bexarotene Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start